BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15202517)

  • 1. Ethical considerations on pharmacogenomics.
    Mordini E
    Pharmacol Res; 2004 Apr; 49(4):375-9. PubMed ID: 15202517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhetoric and hype: where's the 'ethics' in pharmacogenomics?
    Williams-Jones B; Corrigan OP
    Am J Pharmacogenomics; 2003; 3(6):375-83. PubMed ID: 14672518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
    Morley KI; Hall WD
    J Mol Med (Berl); 2004 Jan; 82(1):21-30. PubMed ID: 14598045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailor-made pharmacotherapy: future developments and ethical challenges in the field of pharmacogenomics.
    van Delden J; Bolt I; Kalis A; Derijks J; Leufkens H
    Bioethics; 2004 Aug; 18(4):303-21. PubMed ID: 15449404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics and children: meeting the ethical challenges.
    Freund CL; Clayton EW
    Am J Pharmacogenomics; 2003; 3(6):399-404. PubMed ID: 14672521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics: ethical issues and policy options.
    Buchanan A; Califano A; Kahn J; McPherson E; Robertson J; Brody B
    Kennedy Inst Ethics J; 2002 Mar; 12(1):1-15. PubMed ID: 12211263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ethical implications of stratifying by race in pharmacogenomics.
    Lee SS
    Clin Pharmacol Ther; 2007 Jan; 81(1):122-5. PubMed ID: 17186010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, distributive justice and the promise of pharmacogenomics: ethical considerations.
    Lee SS
    Am J Pharmacogenomics; 2003; 3(6):385-92. PubMed ID: 14672519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethics of pharmacogenomics.
    Neil D; Craigie J
    Monash Bioeth Rev; 2004 Apr; 23(2):9-20. PubMed ID: 15810202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetry in scientific method and limits to cross-disciplinary dialogue: toward a shared language and science policy in pharmacogenomics and human disease genetics.
    Ozdemir V; Williams-Jones B; Graham JE; Preskorn SH; Gripeos D; Glatt SJ; Friis RH; Reist C; Szabo S; Lohr JB; Someya T
    J Investig Med; 2007 Apr; 55(3):130-41. PubMed ID: 17481382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racializing drug design: implications of pharmacogenomics for health disparities.
    Lee SS
    Am J Public Health; 2005 Dec; 95(12):2133-8. PubMed ID: 16257939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics--legal, ethical and regulatory considerations.
    March R; Cheeseman K; Doherty M
    Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging ethical issues in pharmacogenomics: from research to clinical practice.
    Freund CL; Wilfond BS
    Am J Pharmacogenomics; 2002; 2(4):273-81. PubMed ID: 12421098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contributions of pharmacogenomics to enhance the efficiency of randomized clinical trials].
    de Jesús Castillejos-López M; García-Sancho MC; Torres-Espíndola LM; Pérez-Padilla JR
    Rev Invest Clin; 2006; 58(5):512-24. PubMed ID: 17408112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics: ethical issues.
    Sutrop M
    Bioethics; 2004 Aug; 18(4):iii-viii. PubMed ID: 15449403
    [No Abstract]   [Full Text] [Related]  

  • 17. Tailored medicine: whom will it fit? The ethics of patient and disease stratification.
    Smart A; Martin P; Parker M
    Bioethics; 2004 Aug; 18(4):322-42. PubMed ID: 15449405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report.
    Corrigan OP
    J Med Ethics; 2005 Mar; 31(3):144-8. PubMed ID: 15738433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation treatment: pharmacogenetic assessment.
    Munafò MR; Lerman C; Niaura R; Shields AE; Swan GE
    Curr Opin Mol Ther; 2005 Jun; 7(3):202-8. PubMed ID: 15977416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ethical and legal overview of pharmacogenomics: perspectives and issues.
    Sillon G; Joly Y; Feldman S; Avard D
    Med Law; 2008 Dec; 27(4):843-57. PubMed ID: 19202860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.